US 11033537
LPT-723 and immune checkpoint inhibitor combinations and methods of treatment
granted A61KA61K2039/507A61K31/444
Quick answer
US patent 11033537 (LPT-723 and immune checkpoint inhibitor combinations and methods of treatment) held by Biomed Valley Discoveries, Inc. expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Biomed Valley Discoveries, Inc.
- Grant date
- Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K2039/507, A61K31/444, A61K39/3955, A61K39/39558